Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by preeclampsia

Sebastian R. Hobson; Rebecca Lim; Euan M. Wallace

doi:10.1007/978-1-4939-7498-6_27

Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by preeclampsia

Sebastian R. Hobson, Rebecca Lim, Euan M. Wallace

Obstetrics & Gynaecology Monash Health

Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review

3 Citations (Scopus)

Abstract

This chapter describes the methodologies which may be used in the development of a phase I clinical trial investigating a therapy of choice in treating preeclampsia.

Original language	English
Title of host publication	Methods in Molecular Biology
Editors	Padma Murthi, Cathy Vaillancourt
Place of Publication	New York, NY
Publisher	Humana Press
Chapter	27
Pages	335-345
Number of pages	11
ISBN (Electronic)	9781493974986
ISBN (Print)	9781493974979
DOIs	https://doi.org/10.1007/978-1-4939-7498-6_27
Publication status	Published - 2018

Publication series

Name	Methods in Molecular Biology
Publisher	Humana Press, Inc.
Volume	1710
ISSN (Print)	1064-3745
ISSN (Electronic)	1940-6029

Keywords

Clinical trial
Melatonin
Oxidative stress
Preeclampsia

Access to Document

10.1007/978-1-4939-7498-6_27

Link to publication in Scopus

Cite this

Hobson, S. R., Lim, R., & Wallace, E. M. (2018). Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by preeclampsia. In P. Murthi, & C. Vaillancourt (Eds.), Methods in Molecular Biology (pp. 335-345). (Methods in Molecular Biology; Vol. 1710). Humana Press. https://doi.org/10.1007/978-1-4939-7498-6_27

Hobson, Sebastian R. ; Lim, Rebecca ; Wallace, Euan M. / Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by preeclampsia. Methods in Molecular Biology. editor / Padma Murthi ; Cathy Vaillancourt. New York, NY : Humana Press, 2018. pp. 335-345 (Methods in Molecular Biology).

@inbook{7f519b793c0541c381769590c2aa3ac0,

title = "Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by preeclampsia",

abstract = "This chapter describes the methodologies which may be used in the development of a phase I clinical trial investigating a therapy of choice in treating preeclampsia.",

keywords = "Clinical trial, Melatonin, Oxidative stress, Preeclampsia",

author = "Hobson, {Sebastian R.} and Rebecca Lim and Wallace, {Euan M.}",

year = "2018",

doi = "10.1007/978-1-4939-7498-6_27",

language = "English",

isbn = "9781493974979 ",

series = "Methods in Molecular Biology",

publisher = "Humana Press",

pages = "335--345",

editor = "Murthi, {Padma } and Vaillancourt, {Cathy }",

booktitle = "Methods in Molecular Biology",

address = "United States of America",

}

Hobson, SR, Lim, R & Wallace, EM 2018, Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by preeclampsia. in P Murthi & C Vaillancourt (eds), Methods in Molecular Biology. Methods in Molecular Biology, vol. 1710, Humana Press, New York, NY, pp. 335-345. https://doi.org/10.1007/978-1-4939-7498-6_27

Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by preeclampsia. / Hobson, Sebastian R.; Lim, Rebecca ; Wallace, Euan M.

Methods in Molecular Biology. ed. / Padma Murthi; Cathy Vaillancourt. New York, NY : Humana Press, 2018. p. 335-345 (Methods in Molecular Biology; Vol. 1710).

Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review

TY - CHAP

T1 - Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by preeclampsia

AU - Hobson, Sebastian R.

AU - Lim, Rebecca

AU - Wallace, Euan M.

PY - 2018

Y1 - 2018

N2 - This chapter describes the methodologies which may be used in the development of a phase I clinical trial investigating a therapy of choice in treating preeclampsia.

AB - This chapter describes the methodologies which may be used in the development of a phase I clinical trial investigating a therapy of choice in treating preeclampsia.

KW - Clinical trial

KW - Melatonin

KW - Oxidative stress

KW - Preeclampsia

UR - http://www.scopus.com/inward/record.url?scp=85037058006&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-7498-6_27

DO - 10.1007/978-1-4939-7498-6_27

M3 - Chapter (Book)

AN - SCOPUS:85037058006

SN - 9781493974979

T3 - Methods in Molecular Biology

SP - 335

EP - 345

BT - Methods in Molecular Biology

A2 - Murthi, Padma

A2 - Vaillancourt, Cathy

PB - Humana Press

CY - New York, NY

ER -

Hobson SR, Lim R , Wallace EM. Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by preeclampsia. In Murthi P, Vaillancourt C, editors, Methods in Molecular Biology. New York, NY: Humana Press. 2018. p. 335-345. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-7498-6_27